Retrospective analysis of systemic chemotherapy for unresectable advanced biliary tract cancer.

被引:0
|
作者
Ishii, H
Furuse, J
Okusaka, T
Yamao, K
Funakoshi, A
Ohkawa, S
Boku, N
Tanaka, K
Nagase, M
Saisho, H
Sato, T
机构
[1] Natl Canc Ctr Hosp E, Kashiwa, Chiba, Japan
[2] Natl Canc Ctr, Tokyo, Japan
[3] Aichi Canc Ctr, Nagoya, Aichi 464, Japan
[4] Kyushu Natl Canc Ctr, Fukuoka, Japan
[5] Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan
[6] Shizuoka Canc Ctr, Nagaizumi, Shizuoka, Japan
[7] Yokohama City Univ, Yokohama, Kanagawa 232, Japan
[8] Tochigi Canc Ctr, Utsunomiya, Tochigi, Japan
[9] Chiba Univ, Chiba, Japan
[10] Kyoto Univ, Kyoto, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:347S / 347S
页数:1
相关论文
共 50 条
  • [21] A Step Forward in the Treatment of Advanced Biliary Tract Cancer.
    Wolpin, Brian M.
    Mayer, Robert J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (14): : 1335 - 1337
  • [22] Treatment of Patients with Unresectable Advanced Carcinoma of Biliary Tract - Chemotherapy and Surgical Resection
    Morise, Zenichi
    Sugioka, Atsushi
    Tanahashi, Yoshinao
    Okabe, Yasuhiro
    Ikeda, Masahiro
    Kagawa, Tadashi
    Takeura, Chinatsu
    [J]. ANTICANCER RESEARCH, 2009, 29 (05) : 1783 - 1786
  • [23] A multicenter retrospective study of survival benefits of statins in unresectable or recurrent advanced biliary tract cancer patients
    Tsugaru, K.
    Maruki, Y.
    Okamoto, T.
    Sasahira, N.
    Oshima, K.
    Ishigaki, K.
    Noguchi, M.
    Kizawa, R.
    Sawada, R.
    Saito, Y.
    Hirata, K.
    [J]. ANNALS OF ONCOLOGY, 2024, 35 : S128 - S128
  • [24] Chemotherapy outcomes for unresectable and metastatic biliary tract cancers (BTC): Role of fluoropyrimidine (FP) chemotherapy A retrospective analysis.
    Alattar, Mona Lisa
    Levin, Pavel
    Beg, Muhammad S.
    Verma, Udit
    Arriaga, Yull Edwin
    Syed, Samira K.
    Karri, Sirisha
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [25] Evaluation of chemotherapy with cisplatin plus gemcitabine after failure of gemcitabine alone for unresectable or recurrent biliary tract cancer.
    Kameda, Ryo
    Ando, Tomoko
    Kobayashi, Satoshi
    Ueno, Makoto
    Ohkawa, Shinichi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [26] Frequency of severe neutropenia occurring as an adverse events of gemcitabine plus cisplatin chemotherapy in patients with recurrent biliary tract cancer compared to those with unresectable biliary tract cancer.
    Fujishiro, Noriko
    Mitsunaga, Shuichi
    Shinohara, Akira
    Takeno, Misaki K.
    Funazaki, Hideki
    Kimura, Gen
    Watanabe, Kazuo
    Umemoto, Kumiko
    Sasaki, Mitsuhito
    Takahashi, Hideaki
    Imaoka, Hiroshi
    Hashimoto, Yusuke
    Ohno, Izumi
    Ikeda, Masafumi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [27] Treatment outcomes of chemotherapy between unresectable and recurrent biliary tract cancer
    Sasaki, Takashi
    Isayama, Hiroyuki
    Nakai, Yousuke
    Ito, Yukiko
    Yasuda, Ichiro
    Toda, Nobuo
    Yagioka, Hiroshi
    Matsubara, Saburo
    Hanada, Keiji
    Maguchi, Hiroyuki
    Kamada, Hideki
    Hasebe, Osamu
    Mukai, Tsuyoshi
    Okabe, Yoshihiro
    Maetani, Iruru
    Koike, Kazuhiko
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (48) : 18452 - 18457
  • [28] Treatment outcomes of chemotherapy between unresectable and recurrent biliary tract cancer
    Takashi Sasaki
    Hiroyuki Isayama
    Yousuke Nakai
    Yukiko Ito
    Ichiro Yasuda
    Nobuo Toda
    Hiroshi Yagioka
    Saburo Matsubara
    Keiji Hanada
    Hiroyuki Maguchi
    Hideki Kamada
    Osamu Hasebe
    Tsuyoshi Mukai
    Yoshihiro Okabe
    Iruru Maetani
    Kazuhiko Koike
    [J]. World Journal of Gastroenterology, 2014, (48) : 18452 - 18457
  • [29] Influence of obstructive jaundice on chemotherapy in patients with unresectable biliary tract cancer
    Shimizu, Satoshi
    Mitsunaga, Shuichi
    Ohno, Izumi
    Takahashi, Hideaki
    Okuyama, Hiroyuki
    Kuwahara, Akiko
    Okusaka, Takuji
    Ikeda, Masafumi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [30] SAFETY OF COMBINATION CHEMOTHERAPY WITH CISPLATIN AND GEMCITABINE FOR UNRESECTABLE BILIARY TRACT CANCER
    Shibata, Y.
    Kotani, H.
    Ogawa, K.
    Takahashi, M.
    Takase, M.
    Shibata, K.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 162 - 162